TNF Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TNFA and buy or sell other stocks, ETFs, and their options commission-free!About TNFA
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms.
CEOChristopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees2
Employees2
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1989
Founded1989
Employees2
Employees2
TNFA Key Statistics
Market cap1.53M
Market cap1.53M
Price-Earnings ratio-0.01
Price-Earnings ratio-0.01
Dividend yield—
Dividend yield—
Average volume826.90K
Average volume826.90K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$164.00
52 Week high$164.00
52 Week low$3.24
52 Week low$3.24
People also own
Based on the portfolios of people who own TNFA. This list is generated using Robinhood data, and it’s not a recommendation.